Non-teratogenic vitamin A preparation for women of child-bearing age
US5061723A · kind A · utility
11Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1989 |
| Grant date | Oct 29, 1991 |
| Priority date | — |
| Expiry date | May 22, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H13/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
For treatment of acne the glucuronide of retinoic acid (retinoyl .beta.-glucuronide) is orally administered to women of child-bearing age who are capable of conception. This therapy is safer than the oral administration of retinoic acid because retinoic acid glucuronide is essentially non-teratogenic at dose levels effective for the acne treatment. The retinoic acid glucuronide can be in all-trans or 13-cis form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.